Cellectis SA (STU:ZVAA)
€ 1.58 0.1 (6.76%) Market Cap: 158.14 Mil Enterprise Value: 5.54 Mil PE Ratio: 0 PB Ratio: 1.45 GF Score: 69/100

Q3 2021 Cellectis SA Earnings Call Transcript

Nov 05, 2021 / 12:00PM GMT
Release Date Price: €10.2 (+0.99%)
Operator

Greetings, Welcome to the Cellectis Q3 2021 Earnings Call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Eric Dutang, chief Financial Officer. Thank you. You may begin.

Eric Dutang
Cellectis S.A. - CFO

Thank you, and welcome, everyone, to Cellectis' Third Quarter 2021 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks is Dr. Andre Choulika, our Chief Executive Officer; and Dr. Carrie Brownstein, our Chief Medical Officer.

Yesterday evening, Cellectis filed its interim report and press release reporting our financial results for the third quarter and 9-month period ending September 30, 2021. This report and press release are available on our website at cellectis.com.

As a reminder, we make forward-looking statements regarding Cellectis' financial outlook in addition to its manufacturing, regulatory and product development. These statements are subject to risks and uncertainties that may cause actual results to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot